Inicio > Medicina Interna > Síndrome de Guillain-Barre > Página 8

Síndrome de Guillain-Barre

Hartung HP, Kieseier BC, Hughes RAC. Guillain-Barré syndrome after exposure to influenza virus. Lancet Infect Dis. 2010;10(9):643-651

11- Wu J, Xu F, Lu L, et al. Safety and effectiveness of a 2009 H1N1 vaccine in Beijing. N Engl J Med. 2010;363(25):2416-2423.PubMed

12- Grimaldi-Bensouda L, Alpérovitch A, Besson G, et al; GBS-PGRx Study Group. Guillain-Barre syndrome, influenzalike illnesses, and influenza vaccination during seasons with and without circulating A/H1N1 viruses. Am J Epidemiol. 2011;174(3):326-335

13- Dieleman J, Romio S, Johansen K, Weibel D, Bonhoeffer J, Sturkenboom M.VAESCO-GBS Case-Control Study Group. Guillain-Barre syndrome and adjuvanted pandemic influenza A(H1N1) 2009 vaccine: multinational case-control study in Europe. BMJ. 2011;343d3908

PubMeddoi: 10.1136/bmj.d3908.

14- Plasmaferesis en el Sindrome de Guillain Barré. 23 de noviembre de 2012] Disponible en: iCve=211117850013 [PDF]

15- Inicio de un síndrome de GuillainBarré durante la gestación. Mas, M.M.; Morán, E.; Mariño, M. Publicado en Clin Invest Ginecol Obstet. 2012;39:210-2. – vol.39 …

16- From the Department of Medicine, National University of Singapore, Singapore (N.Y.); and the Department of Neurology, Heinrich Heine University, Düsseldorf, Germany (H.-P.H.).Address reprint requests to Dr. Yuki at the Department of Medicine, National University of Singapore, Unit 09-01, Centre for Translational Medicine, 14 Medical Dr., Singapore 117599, Singapore, or at [email protected].

17- GuillainBarré Syndrome — American Academy of Neurology.…

Guideline: IVIg Effective for Certain Nerve and Muscle Disorders, 03.26.2012. Study: GuillainBarré Syndrome Cases Low After 2009 H1N1 Vaccine, 04.13.2010 …

18- IntraMed – Artículos – Síndrome de GuillainBarré – N Engl J Med 2012;366:2294-304.

19- Familial GuillainBarré syndrome: First Indian report Naik KR, Saroja ……2012;…Ann Indian Acad Neurol [serial online] 2012 [cited 2013 Feb 10];15:44-7.

20- GuillainBarré Syndrome — NEJM…/NEJMc1208413 .GuillainBarré Syndrome. N Engl J Med 2012; 367:973-974September 6, 2012DOI: 10.1056/NEJMc1208413. Share: Article …

21- Síndrome de GuillainBarré. Asociación con antagonista de FNTaículos relacionados. 2012-10-15 – Síndrome de GuillainBarré. Asociación con antagonista de FNTa. Rev Med Inst Mex Seguro Soc 2012; 50 (5): 565-567 …

22- Adams RD, Victor M, Ropper AH. Principles of neurology. 6thed. New York: Mc Graw, 1997. p. 1312-1318.

23- Mishu B, Blazer MJ. Role of infection due to compylobacter jejuni in the inhibition of Guillan Barre syndrome. Clin Infect Dis 1993;17:104-108.

24- Mishu B, Blaser MJ. Campylobacter jejuni human immunodeficiency virus and Guillan Barre syndrome (letter). J Infect Dis 1994;115(3):1169-77.

25- Shigenazy K. Campylobacter jejuni shemis from patients with Guillan Barre syndrome belong serogroup 19 and contein B-N-Acetyl glucosamine residues. Ann Neurol 1993;33:243-247.

26- Aspinall GO. Hypopolisacharides of compylobacter jejuni serotype 0-19 structure of care oligosacharide regims from the serostrain and two bacterial isolates from patients with the Guillan Barre syndrome. Biochemistry 1994;33(1):241-49.

27- Asbury AK, Arnason BGW, Adam RD. The inflammatory lesion in acute idiopathic polineuritis. Medicine 1969;48:173.

28- Ropper AH. The CNS in Guillan Barre syndrome. Arch Neurol 1983;40:397-398.

29- Haymaker W, Kernehan JW. The landey Guillain Barre syndrome. Clinoco pathologic report of fifty fatal cases and critique of the literature. Medicine 1949;28:59.

30- Ropper AH. Visual clinical variants and signs in Guillan Barre syndrome. Arch Neurol 1988;45:635.

31- Ropper AH. The Guillain Barre syndrome. New Eng J Med 1992;326:1130-1136.

32- Asbury AK, Cornblath DR. Assessment of current diagnostic criteria of Guillain Barre syndrome. ANN Neurol 1990;27:521-24.

33- Honovar M, Thanavan JK, Hughes RAC. A clinicopathological study of Guillain Barre syndrome. Nine cases and literature review. Brain 1991;114:1245.

34- Enders V, Karch, Toyka KV, Michels M. The spectrum of immune response to campylobacter jejuni and glycoconjugates in Guillain Barre syndrome and other neuroimmunological disorders. Ann Neurol 1993;34136-144.

35- Hartung HP. Immunopathogenesis and treatment of the Guillain Barre syndrome. Muscle Nerve 1995;18(2):137.153.

36- Gilburd B. Autoantibodies to phospholipids and brain extract in patients with Guillain Barre syndrome cross-reactive or pathogenic? Autoimmunity 1993;16(1):22-27.

37- Fisher M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplejia, atoce andareflexia). New Eng J Med 1956;225:57-65.

38- Griffin JW, Yi CY, Ho TW. Guillain Barre syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases. Brain 1995;118:577.

39- McKhann GM, Cornblath DR, Griffin JW, Ho TW, Li CY, Jiang Z. Acute motor axonal neuropathy. A frecuent cause of acute flaccid paralysis in China. Ann Neurol 1993;33:333-342.

40- Feasby TE, Gilbert JJ, Brown WF, Bolton CF, Han AF, Koopman WF. An acute axonal form of Guillain Barre polyneuropathy. Brain 1986;109:1115-26.

41- Ropper AH, Kehne SM. Guillain Barre syndrome management of respiratory failure. Neurology 1985;35:1662.

42- French Cooperative Group. Efficiency of plasma exchange in Guillain Barre syndrome. Ann Neurol 1987;22:753.

43- Guillain Barre study group. Plasmaferesis and acute Guillain Barre syndrome. Neurology 1985;35:1056.

44- Dick JJ. A plasma exchange versus immunoglubulin infusion tonal in chronic inflammatory desmielinating poliradiculoneuropathy. Ann Neurol 1984;36(6):838-845.

45- McKhann GM, Griffin JW, Cornblath DR. Plasmapheresis and Guillain Barre syndrome. Analysis of prognostic factors and the effect of plasmapheresis. Ann Neurology 1988;23:347.

46- Pritchard J.Novel Therapeutic approaches to Guillen